Lifevantage Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-20.6%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$184.2Mnext fiscal year
FY EPS (est.)
$0.57next fiscal year
Monitoring Framework
Key Performance Indicators
Active Accounts Quarterly109K
Gross Margin Quarterly79.0%
Quarterly Revenue Quarterly43.7M
Watch Items
- MindBody GLP-1 System Sales StabilizationTrigger: Sequential stabilization or growth in Americas region revenueAction: Evaluate marketing strategy adjustments and consultant incentives if sales continue to decline.
- CEO Transition ExecutionTrigger: August 5, 2026 (Effective Date of Terrence Moorehead's appointment)Action: Monitor strategic alignment, integration of LoveBiome, and initial operational changes under new leadership.
Research as of 19 Jun 2026